相关实验视频
Updated: Jul 29, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
720
缺乏研究的高酸血症 (慢性病) 治疗目标和新的生物学方法
Ajeeta Anand1, Hideki Aoyagi1,2
1Institute of Life Sciences and Bioengineering, Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba 305-8572, Japan.
Medicina (Kaunas, Lithuania)
|May 27, 2023
概括
在慢性病 (CKD) 中,管理高酸血症至关重要,因为它与血管化有关. 本综述解决了研究缺陷,并提出了新的策略,以改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 公共卫生 公共卫生
背景情况:
- 过血是慢性病 (CKD) 的常见并发症,导致严重的健康问题,如血管化和骨矿物质疾病.
- 随着COVID-19的流行,脏的脆弱性得到了强调,强调迫切需要有效的高酸盐血症管理策略.
- 现有的高酸盐血症治疗方法,如酸盐结合剂,存在局限性和副作用,需要进一步研究.
研究的目的:
- 确定诊断和了解慢性病患者的高酸血症的关键研究缺口.
- 评估当前酸盐结合剂疗法的局限性,并探索影响治疗的社会经济因素.
- 提出包括协生菌和功能性食品在内的新方法,用于预防高酸血症和改善生活质量.
主要方法:
- 本综述综合了关于CKD高酸血症的现有文献,重点关注诊断挑战和治疗局限性.
- 它分析了酸盐结合剂的三级毒性和不良影响的机制.
- 该审查还探讨了社会经济方面,公众意识以及新兴的生物和营养策略.
主要成果:
- 在诊断高酸血症和理解其复杂的毒性方面存在重大差距.
- 目前的酸盐结合剂带来了报告不足的不良影响和社会经济挑战.
- 新的策略,如协生菌和功能性食品显示,有望预防高酸血并提高患者的幸福感.
结论:
- 解决高酸血症诊断和治疗方面的研究缺口对于CKD患者至关重要.
- 需要创新的生物和营养干预措施来改善管理和生活质量.
- 对协生菌和功能性食品的进一步研究可以提供更安全,更有效的高酸血症预防策略.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
51
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
51
01:25Chronic Kidney Disease I: Introduction
48
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
48
01:24Chronic Kidney Disease II: Clinical Manifestations
46
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
46
01:18Chronic Kidney Disease IV: Nursing Management
29
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
29
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
214
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
214
01:20Acute Kidney Injury V: Interprofessional Care
30
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
30